Taiwan News
-
Cytena expands in Asian market with subsidiary in Taiwan
Taiwan | News | 0 Comment | 24 Jul, 2019
Germany based Cytena, the specialist for single-cell technologies, is continuing its growth with the establishment of it...Read more
-
Medeon completes investments in Panther Orthopedics, Prodeon
Taiwan | News | 0 Comment | 09 Jul, 2019
Medeon Biodesign, Inc., a Taiwan publicly traded medical device company, is pleased to announce that it recent...Read more
-
Taiwan focuses on new cost saving medical devices
Taiwan | News | 0 Comment | 08 Jul, 2019
Health professionals, educators, and legislative representatives praised four Taiwanese companies for new medical device...Read more
-
TLC announces new agreement for NanoX immunotherapy product
Taiwan | News | 0 Comment | 27 Jun, 2019
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercializ...Read more
-
Disinfection measure will be taken at Livestock Taiwan Expo 2019 to highlight biosecurity
Taiwan | News | 0 Comment | 26 Jun, 2019
Taiwan Livestock Expo & Forum, an exclusive trade show in Taiwan, brings together more than 15,000 buyers every...Read more
-
Lumosa to Initiate Phase 2 Human Clinical Trial for LT3001 to treat Acute Ischemic Stroke
Taiwan | News | 0 Comment | 14 Jun, 2019
Lumosa Therapeutics, on 13 June 2019, announced that the company is ready to commence the Phase 2 proof of concept (PoC)...Read more
-
Tobacco companies in Taiwan change prices during low taxes
Taiwan | News | 0 Comment | 10 Jun, 2019
New research published in Tobacco Control shows transnational tobacco companies can increase their profits at the e...Read more
-
Taiwan delegation presents capabilities for international collaborations at BIO 2019
Taiwan | News | 0 Comment | 07 Jun, 2019
The world's largest annual event for the biomedical sector, BIO International Convention (BIO 2019), was held in Ph...Read more
-
CStone submits new drug application for TIBSOVO(R) for treatment of relapsed/refractory AML
Taiwan | News | 0 Comment | 03 Jun, 2019
CStone Pharmaceuticals announced that a new drug application (NDA) for TIBSOVO® (ivosidenib) has been submitted...Read more
-
Gilead's Epclusa now available via the NHI scheme in Taiwan
Taiwan | News | 0 Comment | 31 May, 2019
Gilead Sciences has announced that Epclusa (sofosbuvir 400mg/velpatasvir 100mg), a once-daily pan-genotypic, pan-fi...Read more
-
APRINOIA Therapeutics receives grant for Parkinson's Research
Taiwan | News | 0 Comment | 29 May, 2019
APRINOIA Therapeutics, a Taiwan headquartered clinical-stage biotechnology company with a pipeline of therapeutics and i...Read more
-
Taiwanese startups receive boost from French, Swiss health industry
Taiwan | News | 0 Comment | 24 May, 2019
Following the successful visit to Viva Tech 2019 in Paris, Taiwan's Ministry of Science & Technology ...Read more
-
Taiwan | Opinion | 0 Comment | 24 May, 2019
Dr. Nina, Kao Hsiao Ling is the CEO of Overseas Medical Mission Center of Changhua Christian Hospital established in the...Read more
-
Taiwan looking for association in Indian market
Taiwan | News | 0 Comment | 17 May, 2019
The second edition of Taiwan Expo 2019 in New Delhi, India organised by Bureau of Foreign Trade (MOEA) and Taiwan Extern...Read more
-
Researchers develop mobile image recognition system for drugs
Taiwan | News | 0 Comment | 15 May, 2019
A recent study showed that older elderly people consume medicines on an average of 7.3 drugs per day. A wrong drug taken...Read more
-
VolitionRx initiates clinical trial programme in lung cancer
Taiwan | News | 0 Comment | 08 May, 2019
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...Read more
-
EirGenix inks commercialization agreement with Sandoz
Taiwan | News | 0 Comment | 30 Apr, 2019
EirGenix, Inc. has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG, gran...Read more
-
Taiwan Health Ministry approves Vemlidy for chronic hepatitis B
Taiwan | News | 0 Comment | 30 Apr, 2019
Gilead Sciences, Inc. has recently announced that with effect from 1 May 2019, Vemlidy (tenofovir alafenamide, TAF)...Read more
